<SEC-DOCUMENT>0001181431-15-005936.txt : 20150417
<SEC-HEADER>0001181431-15-005936.hdr.sgml : 20150417
<ACCEPTANCE-DATETIME>20150417132847
ACCESSION NUMBER:		0001181431-15-005936
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20150415
FILED AS OF DATE:		20150417
DATE AS OF CHANGE:		20150417

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sagent Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001369786
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE

	BUSINESS ADDRESS:	
		STREET 1:		1901 NORTH ROSELLE ROAD, SUITE 700
		CITY:			SCHAUMBURG
		STATE:			IL
		ZIP:			60195
		BUSINESS PHONE:		847-908-1604

	MAIL ADDRESS:	
		STREET 1:		1901 NORTH ROSELLE ROAD, SUITE 700
		CITY:			SCHAUMBURG
		STATE:			IL
		ZIP:			60195

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Sagent Holding Co.
		DATE OF NAME CHANGE:	20090529

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NHS PHARMACEUTICALS
		DATE OF NAME CHANGE:	20060720

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Yanai Shlomo
		CENTRAL INDEX KEY:			0001562645

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35144
		FILM NUMBER:		15777314

	MAIL ADDRESS:	
		STREET 1:		ONE MEADOWLANDS PLAZA
		CITY:			EAST RUTHERFORD
		STATE:			NJ
		ZIP:			07073
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>rrd424360.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2015-04-15</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001369786</issuerCik>
        <issuerName>Sagent Pharmaceuticals, Inc.</issuerName>
        <issuerTradingSymbol>SGNT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001562645</rptOwnerCik>
            <rptOwnerName>Yanai Shlomo</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O SAGENT PHARMACEUTICALS, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1901 NORTH ROSELLE ROAD, SUITE 700</rptOwnerStreet2>
            <rptOwnerCity>SCHAUMBURG</rptOwnerCity>
            <rptOwnerState>IL</rptOwnerState>
            <rptOwnerZipCode>60195</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2015-04-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>2970</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F2"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>2970</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2970</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Each restricted stock unit represents a contingent right to receive one share of SGNT common stock.</footnote>
        <footnote id="F2">The restricted stock units vest in four equal annual installments beginning on April 15, 2016. Vested shares will generally be delivered to the reporting person within 30 days following the vesting date.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Shlomo Yanai</signatureName>
        <signatureDate>2015-04-15</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>